Johnson & Johnson allies with biotech startup on HIV drug in China

Ryan McBride The biopharma startup Ascletis has snagged exclusive rights from Johnson & Johnson's ($ JNJ) Janssen for an experimental HIV protease inhibitor for the China ...

Japan’s Eisai amps up in China with new manufacturing plant

Tracy Staton Eisai is drawing a bigger target on China with plans for a new manufacturing plant near Suzhou. The Japanese drugmaker will use the plant to tap growing demand in that ...

Roche, billionaire-backed biotech partner on hep C drug in China

Ryan McBride Roche ($ RHHBY) and the biotech startup Ascletis have joined forces to advance Roche's experimental drug danoprevir for hepatitis C virus in the Chinese market. As ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS